Kay Huh

537 total citations
9 papers, 137 citations indexed

About

Kay Huh is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kay Huh has authored 9 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kay Huh's work include PI3K/AKT/mTOR signaling in cancer (3 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Kay Huh is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Kay Huh collaborates with scholars based in Switzerland and United States. Kay Huh's co-authors include Ribhi M. Shawar, Matthew T. Burger, William R. Baker, Liming Fang, Joseph Therrien, Martin Dimitroff, Xiao Shang, Charles F. Voliva, Marion Wiesmann and Mark Knapp and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Kay Huh

9 papers receiving 134 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kay Huh Switzerland	7	81	55	22	20	15	9	137
Guanjing Chen United States	4	123 1.5×	63 1.1×	34 1.5×	16 0.8×	9 0.6×	4	182
Jen-Shin Song Taiwan	10	111 1.4×	86 1.6×	24 1.1×	42 2.1×	6 0.4×	14	254
Alastair Donald United Kingdom	6	202 2.5×	117 2.1×	45 2.0×	7 0.3×	13 0.9×	8	274
Lakshminarayana Vogeti United States	7	58 0.7×	56 1.0×	33 1.5×	5 0.3×	21 1.4×	10	165
Elena Critselis Greece	5	97 1.2×	26 0.5×	28 1.3×	6 0.3×	16 1.1×	5	165
Ayah Abdeldayem Canada	1	158 2.0×	105 1.9×	52 2.4×	19 0.9×	8 0.5×	2	214
Raimon Puig de la Bellacasa Spain	11	82 1.0×	161 2.9×	42 1.9×	13 0.7×	15 1.0×	23	262
Suzannah J. Harnor United Kingdom	8	119 1.5×	27 0.5×	47 2.1×	7 0.3×	4 0.3×	12	177
Jitendra K. Mishra India	7	113 1.4×	103 1.9×	35 1.6×	4 0.2×	12 0.8×	20	238
Gillian M. Lamont United Kingdom	8	156 1.9×	75 1.4×	58 2.6×	7 0.3×	10 0.7×	15	243

Countries citing papers authored by Kay Huh

Since Specialization

Citations

This map shows the geographic impact of Kay Huh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Huh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Huh more than expected).

Fields of papers citing papers by Kay Huh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Huh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Huh. The network helps show where Kay Huh may publish in the future.

Co-authorship network of co-authors of Kay Huh

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Huh. A scholar is included among the top collaborators of Kay Huh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Huh. Kay Huh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Smith, Aaron, Zhi‐Jie Ni, Daniel Poon, et al.. (2017). Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(23). 5221–5224. 8 indexed citations

Han, Wooseok, Daniel L. Menezes, Yongjin Xu, et al.. (2016). Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model. Bioorganic & Medicinal Chemistry Letters. 26(3). 742–746. 20 indexed citations

Pecchi, Sabina, Zhi‐Jie Ni, Wooseok Han, et al.. (2013). Structure guided optimization of a fragment hit to imidazopyridine inhibitors of PI3K. Bioorganic & Medicinal Chemistry Letters. 23(16). 4652–4656. 6 indexed citations

Voliva, Charles F., Sabina Pecchi, Matthew T. Burger, et al.. (2010). Abstract 4498: Biological characterization of NVP-BKM120, a novel inhibitor of phosphoinosotide 3-kinase in Phase I/II clinical trials. Cancer Research. 70(8_Supplement). 4498–4498. 29 indexed citations

Wiesmann, Marion, Dylan Daniel, Nancy Pryer, et al.. (2010). Abstract 3629: BLZ945, a selective c-fms (CSF-1R) kinase inhibitor for the suppression of tumor-induced osteolytic lesions in bone. Cancer Research. 70(8_Supplement). 3629–3629. 9 indexed citations

Burger, Matthew T., Xiaodong Lin, Daniel T. W. Chu, et al.. (2006). Synthesis and Antibacterial Activity of Novel C₁₂ Vinyl Ketolides. Journal of Medicinal Chemistry. 49(5). 1730–1743. 19 indexed citations

Baker, William R., Martin Dimitroff, Liming Fang, et al.. (2004). A Prodrug Approach toward the Development of Water Soluble Fluoroquinolones and Structure−Activity Relationships of Quinoline-3-carboxylic Acids. Journal of Medicinal Chemistry. 47(19). 4693–4709. 38 indexed citations

Jeffry, Ursula, et al.. (2004). Immunological Profile and Safety Evaluation in a 23-Week Single Dose Study in Cynomolgus Monkey with CHIR-12.12, a Fully Human Antagonist Anti-CD40 Antibody.. Blood. 104(11). 4638–4638. 3 indexed citations

Jeffry, Ursula, Kay Huh, Tong Xia, et al.. (2004). Safety Evaluation of an Fully Human Antagonist Anti-CD40 Antibody, CHIR-12.12, in a Dose Range-Finding Study in Cynomolgus Monkeys.. Blood. 104(11). 3282–3282. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact